Inspire Medical Systems, Inc. (INSP)
After hours:
| Previous close | 234.19 |
| Open | 231.41 |
| Bid | 0.00 x 1100 |
| Ask | 0.00 x 800 |
| Day's range | 224.06 - 231.68 |
| 52-week range | 123.27 - 330.00 |
| Volume | |
| Avg. volume | 503,130 |
| Market cap | 6.999B |
| Beta (5Y monthly) | 1.40 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Inspire Medical Systems, Inc. to Report First Quarter 2024 Financial Results on May 7, 2024
MINNEAPOLIS, April 02, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2024 after the close of trading on Tuesday, May 7. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments. A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspir
- GlobeNewswire
Inspire Medical Systems, Inc. to Present at the KeyBanc Life Sciences & MedTech Investor Forum
MINNEAPOLIS, March 05, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the KeyBanc Life Sciences and MedTech Investor Forum on Tuesday, March 19, 2024. Inspire is scheduled to present at 10:30 a.m. Eastern Time. The presentation will be accessible
- GlobeNewswire
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results and Reaffirms 2024 Outlook
Inspire Reports First Quarter with Operating Income and Year-over-Year Revenue Growth of 40% in the Fourth Quarter MINNEAPOLIS, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter and year ended December 31, 2023. Recent Business Highlights and Full
